BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

CNTB

No price yet

Announcements

Nothing here yet

Daily updates

  • Connect Biopharma reported positive Phase 2 Seabreeze STAT COPD topline data for single-dose rademikibart in acute COPD exacerbations with type 2 inflammation.Sep 30, 2026
  • Connect Biopharma reported positive Phase 2 Seabreeze STAT asthma results for rademikibartSep 16, 2026
  • Connect Biopharma reported positive Phase 2 Seabreeze STAT asthma results for rademikibartSep 15, 2026
  • Rademikibart Phase 2b asthma data were expected in early September 2026Sep 7, 2026

FDA designations

Nothing here yet

News

  • Connect Biopharma reports positive preliminary topline results from its global Phase 2 trial of rademikibart as add-on therapy for acute COPD exacerbations in adults with type 2 inflammationSep 30, 2026
  • Connect Biopharma reported positive preliminary topline data from its global Phase 2 study of rademikibart as an add-on treatment for acute asthma exacerbations with Type 2 inflammationSep 15, 2026
  • Connect Biopharma completed enrollment in the Phase 2 Seabreeze STAT asthma study of rademikibartJun 18, 2026
  • Connect Biopharma plans to terminate its ADR program and directly list ordinary shares on NasdaqJul 21, 2025
  • Connect Biopharma's exclusive licensee Simcere submits new drug application for Rademikibart to treat atopic dermatitis in ChinaJul 9, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2024-2026 Bio Pharma Stock. All rights reserved. Policy